# SpyGlass™ Discover Percutaneous

> **NCT04580940** · — · COMPLETED · sponsor: **Boston Scientific Corporation** · enrollment: 50 (actual)

## Conditions studied

- Pancreatic Diseases
- Bile Duct Obstruction
- Bile Duct Diseases

## Interventions

- **DEVICE:** SpyGlass™ Discover Digital System

## Key facts

- **NCT ID:** NCT04580940
- **Lead sponsor:** Boston Scientific Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-07-27
- **Primary completion:** 2022-12-14
- **Final completion:** 2023-01-14
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2023-11-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04580940

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04580940, "SpyGlass™ Discover Percutaneous". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04580940. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*